- Home
- PDM vs ATTO Comparison
PDM vs ATTO Comparison
Compare PDM & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PDM | ATTO |
|---|---|---|
| Founded | 1997 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 1997 | 2026 |
Fundamental Metrics
Financial Performance| Metric | PDM | ATTO |
|---|---|---|
| Price | $9.63 | $14.49 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | $10.75 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 1.3M | 419.6K |
| Earning Date | 10-26-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $564,994,000.00 | N/A |
| Revenue This Year | $3.29 | N/A |
| Revenue Next Year | $2.41 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.32 | $12.94 |
| 52 Week High | $10.13 | $28.00 |
Technical Indicators
Market Signals| Indicator | PDM | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 61.99 | 34.03 |
| Support Level | $9.28 | $12.94 |
| Resistance Level | $9.97 | $15.54 |
| Average True Range (ATR) | 0.23 | 1.23 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 92.78 | 26.86 |
Price Performance
Historical ComparisonAbout PDM Piedmont Office Realty Trust Inc.
Piedmont Realty Trust Inc is a fully integrated, self-managed real estate investment company focused on delivering an exceptional office environment. As an owner, manager, developer and operator of 16 MM SF of Class A properties across U.S. Sunbelt markets, Piedmont Realty Trust is known for its hospitality-driven approach and commitment to transforming buildings into Piedmont PLACEs that enhance each client's workplace experience.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.